| Generic Name | Tradename | Applicant | NDA | Approval Date | Type | Patent Number | Patent Expiration | Patented / Exclusive Use | | sitagliptin phosphate | JANUVIA | Merck Co Inc | 021995 | Oct 16, 2006 | RX |
7,326,708 | Apr 11, 2026 | METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR | | sitagliptin phosphate | JANUVIA | Merck Co Inc | 021995 | Oct 16, 2006 | RX |
7,326,708 | Apr 11, 2026 | METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR | | sitagliptin phosphate | JANUVIA | Merck Co Inc | 021995 | Oct 16, 2006 | RX |
7,326,708 | Apr 11, 2026 | METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR | | metformin hydrochloride; sitagliptin phosphate | JANUMET | Merck | 022044 | Mar 30, 2007 | RX |
7,326,708 | Apr 11, 2026 | METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR | | metformin hydrochloride; sitagliptin phosphate | JANUMET | Merck | 022044 | Mar 30, 2007 | RX |
7,326,708 | Apr 11, 2026 | METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING A DIPEPTIDYL PEPTIDASE-IV INHIBITOR |
|